Heart Rhythm Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
Heart Rhythm Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 1):1333-1339. doi: 10.1016/j.jacep.2022.12.016. Epub 2023 Feb 22.
The wearable cardioverter-defibrillator (WCD) prevents sudden cardiac death due to ventricular tachycardia (VT) or ventricular fibrillation (VF) but does not pace for post-shock asystole (PS-A) or bradycardia (PS-B;<50 beats/ min).
The purpose of this study was to assess PS-A and PS-B in patients dying out of hospital (OOH) while wearing a WCD.
The database of the U.S. Food and Drug Administration Manufacturers and User Facility Device Experience (MAUDE) was queried for manufacturers' reports of OOH deaths while patients were wearing a WCD. Excluded were patients who did not receive a shock or were initially shocked for asystole or during resuscitation.
From January 2017 to March 2022, 313 patients received an initial WCD shock for VF (n = 150), VT (n = 90), and non-VF/VT rhythms (n = 73). PS-A occurred in 204 patients (65.2%), and PS-B occurred in 111 (35.5%); 85 (41.7%) PS-A patients also had PS-B. Most PS-A patients (n = 185; 90.7%) had an initial shocked rhythm of VF or VT, but 19 patients (9.3%) were initially inappropriately shocked for atrial fibrillation/supraventricular tachycardia (n = 7) and idioventricular (n = 8) or sinus (n = 4) rhythm. PS-A occurred after the first WCD shock in 118 (63.8%) and after the first, second, or third shocks in 159 patients (85.9%). Seven patients had post-shock heart block. Eight patients had permanent pacemakers; 1 became nonfunctional after 1 shock, and 7 showed noncapture and/or asystole after 1 to 4 shocks.
Post-shock asystole appears to be common in patients who die OOH after being shocked by a WCD for VF or VT. PS-A also occurs after inappropriate WCD shocks for non-VF/VT rhythms. Implanted pacemakers may not prevent PS-A after a WCD shock. WCD backup pacing should be explored.
可穿戴式除颤器(WCD)可预防因室性心动过速(VT)或心室颤动(VF)导致的心脏性猝死,但不能对电击后停搏(PS-A)或心动过缓(PS-B;<50 次/分)进行起搏。
本研究旨在评估 WCD 佩戴患者院外心脏骤停(OOH)时的 PS-A 和 PS-B。
检索美国食品和药物管理局制造商和用户设施设备体验(MAUDE)数据库,获取制造商报告的 OOH 死亡病例,这些患者在佩戴 WCD 时发生了电击。排除未接受电击或初始电击用于停搏或复苏的患者。
2017 年 1 月至 2022 年 3 月,313 例患者因 VF(n=150)、VT(n=90)和非 VF/VT 节律(n=73)接受初始 WCD 电击。204 例(65.2%)发生 PS-A,111 例(35.5%)发生 PS-B;85 例(41.7%)PS-A 患者同时存在 PS-B。大多数 PS-A 患者(n=185;90.7%)初始受电击的节律为 VF 或 VT,但 19 例(9.3%)初始被不适当电击,用于治疗房颤/室上性心动过速(n=7)、室性自主节律(n=8)或窦性节律(n=4)。118 例(63.8%)PS-A 发生在首次 WCD 电击后,159 例(85.9%)发生在首次、第二次或第三次电击后。7 例患者电击后出现心脏传导阻滞。8 例患者植入了永久性起搏器;1 例在首次电击后失去功能,7 例在 1 至 4 次电击后显示无夺获和/或停搏。
VF 或 VT 电击后 OOH 死亡的患者,电击后停搏似乎很常见。非 VF/VT 节律的不适当 WCD 电击后也会发生 PS-A。WCD 电击后植入的起搏器可能无法预防 PS-A。应探索 WCD 备用起搏。